How many UTIs constitute a recurrent UTI?

A recurrent UTI is medically defined as two or more confirmed urinary tract infections within a 6-month period, or three or more infections within a 12-month period.

Why do I keep getting UTIs even after taking antibiotics?

Recurrent UTIs despite antibiotic treatment can occur due to antibiotic resistance, reinfection, incomplete eradication, or underlying anatomical or hormonal factors. A specialist evaluation with urine culture is essential.

Can recurrent UTIs be prevented?

Yes - recurrent UTIs can often be significantly reduced or eliminated with the right prevention strategy including low-dose antibiotic prophylaxis, vaginal estrogen therapy for postmenopausal women, behavioral modifications, and evidence-based supplements.

Do I need to see an infectious disease specialist or can my primary care doctor treat recurrent UTIs?

While primary care physicians can treat individual UTI episodes, recurrent UTIs benefit significantly from infectious disease specialist evaluation with specialized training in antibiotic resistance patterns and evidence-based prevention strategies.

Is long-term antibiotic use for UTI prevention safe?

Low-dose antibiotic prophylaxis for recurrent UTI prevention has a well-established safety record when properly managed. Specialists carefully select the safest antibiotic at the lowest effective dose and regularly reassess.

Does Atlas IDP accept insurance for recurrent UTI treatment?

Yes, Atlas Infectious Disease Practice accepts most major insurance plans. Call (561) 995-6971 to verify your specific insurance coverage before your appointment.

Infectious Disease Archives

The Importance to Address and Help Visceral Adiposity in HIV Patients

Clinical Insights on HIV-Associated Visceral Fat Following FDA Approval of Tesamorelin F8

FDA Approves F8 Formulation of Theratechnologies’ Tesamorelin for HIV-Associated Lipodystrophy

FDA Approves Gepotidacin (Blujepa) for Uncomplicated Urinary Tract Infections

A Focus on At-Risk Populations

With the Rise of COVID-19 Vaccines, a Greater Public Mistrust of Immunizations Has Taken Hold

EU Approval Progress and Global Access

Improving TB Detection and Treatment in Uganda Through Household Screening and Sputum Monitoring

Identifying Invasive Pneumococci in Pediatric Infections Utilizing Whole Genome Sequencing

Childhood TB Cases Surge in the EU/EEA

Schedule an Appointment

Quick Links

Patient Forms

Contact Us